InvestorsHub Logo
Followers 14
Posts 390
Boards Moderated 0
Alias Born 10/12/2012

Re: rodman post# 530

Monday, 12/04/2017 10:16:15 AM

Monday, December 04, 2017 10:16:15 AM

Post# of 13643
This is all looking really really good!

I posted the whole news release because your link needed an etrade login :)

I really like this part:

The FDA selected UHP’s HemoStyp as only one of nine participants for the program.



And this:

Concurrent with its CtQ Pilot Program participation, UHP reaffirms that its current Class II application – Expanded Indication submission with the US FDA – continues to progress, and is in an advanced stage of review.